Savvy issuers with outstanding convertible debt are taking advantage of the opportunity to consolidate debt and generate new working capital under JMJ’s new refinancing program. By focusing their relationship with one leading investor, they help prevent excessive dilution and share price pressure from multiple lenders converting simultaneously.
$1,000,000: a green energy and renewable technologies company.
$500,000: a healthcare company that operates medical clinics offering expert care in the treatment and recovery of substance abuse issues.
$650,000: a bio-pharmaceutical company engaged in the development and commercialization of targeted immune therapies.
$1,000,000: a developer of electrically conductive hybrid plastics used in the production of industrial, commercial, and consumer products.
Consolidating debt with a financial partner committed to supporting the issuer’s long-term success merits strong consideration. Contact us to learn more about JMJ’s new debt consolidation options for your company or clients.